Marvin Kronenberg is a Cardiology physician affiliated with Vanderbilt University. OpenAlex indexes 101 publications with 3,495 citations (h-index 26); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Vanderbilt Heart And Vascular Inst 1215 21st Ave S
Suite 5209
Nashville, TN 372320001
Telephone
615-322-2318Provider last certified this registry record 16 Oct 2024.
Clinical trials
- Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF
Sponsor: Marvin W. Kronenberg, M.D.
- Effect of Aldosterone on Energy Starvation in Heart Failure
Sponsor: Vanderbilt University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- PFIZER INC.Program year20241 payment
- Alnylam Pharmaceuticals Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.9%Statin19%Atorvastatin Calcium70%Rosuvastatin Calcium24%Pravastatin Sodium6%Part D<11 patientsBeta blocker15.9%Metoprolol Succinate42%Carvedilol34%Metoprolol Tartrate23%Part D≥21 patients+ 10 more classes in this area
Metabolism & gastrointestinal
8.5%Potassium supplement3.2%Potassium Chloride100%Part D≥11 patientsProton pump inhibitor3.1%Omeprazole68%Pantoprazole Sodium32%Part D<11 patients+ 1 more class in this area
Blood & clotting
4.6%Factor Xa inhibitor2.2%Eliquis100%Part D≥11 patientsP2Y12 inhibitor1.4%Clopidogrel100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 1985–1990 per NIH RePORTER. The latest:
- FUNCTIONAL CONSEQUENCES OF LEFT VENTRICULAR HYPERTROPHY/REGRESSION
Vanderbilt University
FY1990M01RR000095
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial
Journal of the American Heart Association
2024 - Myocardial Perfusion and Viability Imaging in Coronary Artery Disease: Clinical Value in Diagnosis, Prognosis, and Therapeutic Guidance
The American Journal of Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
James Crowe, MD
Vanderbilt University
Ingrid Mayer, MD
Vanderbilt University
Michael Debaun, MD
Vanderbilt University
Sam Chang, MD
Vanderbilt University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”